ACLID, INC. — Department of Defense SBIR Phase I: X224-OCSO1

Description

Aclid is adapting its commercial platform for Air Force needs. End-users will receive early warnings when human error risks the creation of a novel or existing biothreat. At the same time, end-users will be alerted if nefarious actors attempt to generate a man-made biothreat anywhere in the world. Aclid is a proprietary software platform that ensures security and safety for synthetic biology work, including cloning, virus research, and biosensor development. As gene synthesis becomes more accessible across the globe, concerns around security (e.g., pathogenic sequences, bioterrorism) increase. As a service operating in austere environments, the USAF must recognize its role in preventing the spread of future biothreats. Aclid is the only end-to-end DNA screening platform in existence. Users can gain necessary bioinformation on each use, including organism name, gene ontology, virulence, and function. Our platform flags hits in USDA Select Agent & Toxins List, Australia Group Common Control List, U.S Commerce Control List, and EU Dual Use List.